Reported about 22 hours ago
Pfizer has appointed Chris Boshoff, a company veteran with over a year of experience in cancer research and marketing, as its new chief of research and development, effective January 1. This decision follows criticism from activist investor Starboard regarding Pfizer's management and its struggle to produce profitable new drugs. Boshoff will oversee all R&D functions as the company addresses declining sales from its COVID-19 vaccine and antiviral treatments.
Source: YAHOO